Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (29) Blankenstein, Thomas Prof. Dr. (21) Bunse, Mario Dr. (1) Cano Rincon, Elena Dr. (3) Collins, Russell Thomas Dr. (2) Edes, Inan Dr. (1) Fischer, Cornelius Dr. (1) Gerhardt, Holger Prof. Dr. (21) Kettenmann, Helmut Prof. Dr. (30) Kieback, Elisa Dr. (1) Krabbe, Grietje Dr. (3) Ku, Min-Chi Dr. (3) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lewin, Gary Prof. Dr. (1) Lupianez Garcia, Dario Jesus Dr. (1) Maglione, Marta (1) Niendorf, Thoralf Prof. Dr. (3) Nolte, Christiane Dr. (2) Pezzutto, Antonio Prof. Dr. (1) Potente, Michael Prof. Dr. (2) Rajewsky, Klaus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Waiczies, Helmar Dr. (3) Waiczies, Sonia PD Dr. (4) Willimsky, Gerald Dr. (5) Wolf, Susanne Dr. (8) (-) Harabula, Izabela-Cezara (1) (-) Kammertöns, Thomas Dr. (8) (-) Kopp, Joachim Dr. (1) (-) Semtner, Marcus Dr. (2) 1998 (1) 1999 (1) 2000 (3) 2001 (1) 2003 (1) 2004 (3) 2005 (4) 2007 (1) 2009 (3) 2010 (2) 2011 (3) (-) 2012 (3) (-) 2013 (5) 2014 (2) 2015 (3) (-) 2016 (4) 2017 (3) 2018 (2) 2019 (5) 2020 (7) 2021 (2) 2022 (4) 2023 (3) Cancer Genetics and Cellular Stress Responses (1) Cardiac MRI (1) (-) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (7) Genetics of Metabolic and Reproductive Disorders (1) Genome Engineering & Disease Models (2) (-) Genomics (1) Immune Regulation and Cancer (3) Magnetic Resonance (7) (-) Molecular Immunology and Gene Therapy (9) Proteome Dynamics (2) RNA Biology and Posttranscriptional Regulation (3) Transgenics (2) 12 Results: Active Filter: Harabula, Izabela-CezaraKammertöns, Thomas Dr.Kopp, Joachim Dr.Semtner, Marcus Dr.Cellular NeurosciencesGenomicsMolecular Immunology and Gene Therapy201220132016 Sort: Result score Newest to oldest Oldest to newest December 01, 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya December 01, 2016 / Cell Calcium Spontaneous Ca(2+) transients in mouse microglia L. Korvers A. de Andrade Costa M. Mersch V. Matyash H. Kettenmann M. Semtner February 01, 2016 / Genome Res Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice M. Spielmann N. Kakar N. Tayebi C. Leettola G. Nürnberg N. Sowada D.G. Lupiáñez I. Harabula R. Flöttmann D. Horn W.L. Chan L. Wittler R. Yilmaz J. Altmüller H. Thiele H. van Bokhoven C.E. Schwartz P. Nürnberg J.U. Bowie J. Ahmad C. Kubisch S. Mundlos G. Borck October 01, 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein December 01, 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens March 30, 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel February 05, 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein August 19, 2016 / J Biol Chem Electrophysiological signature of homomeric and heteromeric glycine receptor channels C. Raltschev F. Hetsch A. Winkelmann J.C. Meier M. Semtner Pagination Current page 1 Page 2 Next page Next › Last page Last »
December 01, 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya
December 01, 2016 / Cell Calcium Spontaneous Ca(2+) transients in mouse microglia L. Korvers A. de Andrade Costa M. Mersch V. Matyash H. Kettenmann M. Semtner
February 01, 2016 / Genome Res Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice M. Spielmann N. Kakar N. Tayebi C. Leettola G. Nürnberg N. Sowada D.G. Lupiáñez I. Harabula R. Flöttmann D. Horn W.L. Chan L. Wittler R. Yilmaz J. Altmüller H. Thiele H. van Bokhoven C.E. Schwartz P. Nürnberg J.U. Bowie J. Ahmad C. Kubisch S. Mundlos G. Borck
October 01, 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein
December 01, 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
March 30, 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm
February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
February 05, 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
August 19, 2016 / J Biol Chem Electrophysiological signature of homomeric and heteromeric glycine receptor channels C. Raltschev F. Hetsch A. Winkelmann J.C. Meier M. Semtner